These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 28993193

  • 1. α-Lipoic acid inhibits human lung cancer cell proliferation through Grb2-mediated EGFR downregulation.
    Yang L, Wen Y, Lv G, Lin Y, Tang J, Lu J, Zhang M, Liu W, Sun X.
    Biochem Biophys Res Commun; 2017 Dec 09; 494(1-2):325-331. PubMed ID: 28993193
    [Abstract] [Full Text] [Related]

  • 2. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
    Kim DI, Lee SJ, Lee SB, Park K, Kim WJ, Moon SK.
    Carcinogenesis; 2008 Sep 09; 29(9):1701-9. PubMed ID: 18296682
    [Abstract] [Full Text] [Related]

  • 3. α-Lipoic acid-induced inhibition of proliferation and met phosphorylation in human non-small cell lung cancer cells.
    Michikoshi H, Nakamura T, Sakai K, Suzuki Y, Adachi E, Matsugo S, Matsumoto K.
    Cancer Lett; 2013 Jul 28; 335(2):472-8. PubMed ID: 23507559
    [Abstract] [Full Text] [Related]

  • 4. Simvastatin induces G1 arrest by up-regulating GSK3β and down-regulating CDK4/cyclin D1 and CDK2/cyclin E1 in human primary colorectal cancer cells.
    Chen MJ, Cheng AC, Lee MF, Hsu YC.
    J Cell Physiol; 2018 Jun 28; 233(6):4618-4625. PubMed ID: 28833099
    [Abstract] [Full Text] [Related]

  • 5. Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E.
    Gumina MR, Xu C, Chiles TC.
    Cell Cycle; 2010 Feb 15; 9(4):820-8. PubMed ID: 20107311
    [Abstract] [Full Text] [Related]

  • 6. Knockdown of interferon-induced transmembrane protein 1 inhibited proliferation, induced cell cycle arrest and apoptosis, and suppressed MAPK signaling pathway in pancreatic cancer cells.
    Zhang L, Wang Z, Kong D, Zhao X, Chen X, Chai W.
    Biosci Biotechnol Biochem; 2020 Aug 15; 84(8):1603-1613. PubMed ID: 32434425
    [Abstract] [Full Text] [Related]

  • 7. The proliferative effects of Pyropia yezoensis peptide on IEC-6 cells are mediated through the epidermal growth factor receptor signaling pathway.
    Lee MK, Kim IH, Choi YH, Choi JW, Kim YM, Nam TJ.
    Int J Mol Med; 2015 Apr 15; 35(4):909-14. PubMed ID: 25716690
    [Abstract] [Full Text] [Related]

  • 8. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.
    Said AH, Hu S, Abutaleb A, Watkins T, Cheng K, Chahdi A, Kuppusamy P, Saxena N, Xie G, Raufman JP.
    Biochem J; 2017 Feb 20; 474(5):647-665. PubMed ID: 28008134
    [Abstract] [Full Text] [Related]

  • 9. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
    Barzegar M, Ma S, Zhang C, Chen X, Gu Y, Shang C, Jiang X, Yang J, Nathan CA, Yang S, Huang S.
    Br J Cancer; 2017 Oct 10; 117(8):1154-1163. PubMed ID: 28873083
    [Abstract] [Full Text] [Related]

  • 10. A novel anticancer agent, SKLB70359, inhibits human hepatic carcinoma cells proliferation via G0/G1 cell cycle arrest and apoptosis induction.
    Dai XY, Zeng XX, Peng F, Han YY, Lin HJ, Xu YZ, Zhou T, Xie G, Deng Y, Mao YQ, Yu LT, Yang L, Zhao YL.
    Cell Physiol Biochem; 2012 Oct 10; 29(1-2):281-90. PubMed ID: 22415097
    [Abstract] [Full Text] [Related]

  • 11. TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase.
    Takeuchi S, Kasamatsu A, Yamatoji M, Nakashima D, Endo-Sakamoto Y, Koide N, Takahara T, Shimizu T, Iyoda M, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    Biochem Biophys Res Commun; 2017 Apr 29; 486(2):385-390. PubMed ID: 28315328
    [Abstract] [Full Text] [Related]

  • 12. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
    Jeannot V, Busser B, Brambilla E, Wislez M, Robin B, Cadranel J, Coll JL, Hurbin A.
    Int J Cancer; 2014 Jun 01; 134(11):2560-71. PubMed ID: 24374738
    [Abstract] [Full Text] [Related]

  • 13. Endocytosis separates EGF receptors from endogenous fluorescently labeled HRas and diminishes receptor signaling to MAP kinases in endosomes.
    Pinilla-Macua I, Watkins SC, Sorkin A.
    Proc Natl Acad Sci U S A; 2016 Feb 23; 113(8):2122-7. PubMed ID: 26858456
    [Abstract] [Full Text] [Related]

  • 14. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
    Kang J, Sergio CM, Sutherland RL, Musgrove EA.
    BMC Cancer; 2014 Jan 20; 14():32. PubMed ID: 24444383
    [Abstract] [Full Text] [Related]

  • 15. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
    Li A, Wang J, Wu M, Zhang X, Zhang H.
    Eur J Pharmacol; 2015 Jan 15; 747():71-87. PubMed ID: 25498792
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
    Tao JL, Luo M, Sun H, Zhao HM, Sun QS, Huang ZM.
    Kaohsiung J Med Sci; 2020 Jun 15; 36(6):417-422. PubMed ID: 32052576
    [Abstract] [Full Text] [Related]

  • 17. Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.
    Ambrosini G, Cheema HS, Seelman S, Teed A, Sambol EB, Singer S, Schwartz GK.
    Mol Cancer Ther; 2008 Apr 15; 7(4):890-6. PubMed ID: 18413802
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest.
    Magatti M, De Munari S, Vertua E, Parolini O.
    J Cell Mol Med; 2012 Sep 15; 16(9):2208-18. PubMed ID: 22260183
    [Abstract] [Full Text] [Related]

  • 20. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W.
    Cancer Lett; 2006 Jul 28; 239(1):27-35. PubMed ID: 16169661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.